Skip to main navigation Skip to search Skip to main content

Ripretinib for advanced gastrointestinal stromal tumours – Authors' reply

Research output: Contribution to journalLetterpeer-review

2 Scopus citations
Original languageEnglish
Pages (from-to)e415
JournalThe Lancet Oncology
Volume21
Issue number9
DOIs
StatePublished - Sep 2020

Keywords

  • Double-Blind Method
  • Gastrointestinal Neoplasms
  • Gastrointestinal Stromal Tumors
  • Humans

Fingerprint

Dive into the research topics of 'Ripretinib for advanced gastrointestinal stromal tumours – Authors' reply'. Together they form a unique fingerprint.

Cite this